Stock listing
Nuvalent, Inc.
Selected listing: NUVL · BX · CHF · CH
Nuvalent, Inc. (BX Swiss: NUVL), Health Technology. Latest release Jun 10, 2026: Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be…
- Ticker
- BX Swiss: NUVL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX Swiss
- Currency
- CHF
About Nuvalent, Inc.
Nuvalent, Inc. is a public company listed under the ticker NUVL, operating in the American market. Nuvalent focuses on developing targeted therapies for cancer treatment.
Latest news from Nuvalent, Inc.
Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
June 10, 2026
Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL
June 10, 2026
Nuvalent : GSK enters agreement to acquire Nuvalent, Inc.
June 9, 2026
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
May 26, 2026
Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026